Federal authorities are proposing to reclassify marijuana as a less dangerous drug
Use of Car-T for lupus could drive surge in demand for a treatment that was first approved for blood cancers
Lessons from other countries highlight importance of political consensus to fix chronic funding shortfall
Pharma group seeks to catch up with rivals Eli Lilly and Novo Nordisk in sector projected to be worth $130bn a year
Health services in comparable countries have recovered faster than England, study finds
US-listed pharmacy group’s problems have been exacerbated by its struggle to move into healthcare
Incubator Flagship Pioneering plans to finance and launch array of companies using AI for pharmaceutical development
Review could be used to build support for health secretary’s reform plans
Spanish medicine maker was rocked earlier this year by allegations of fraud
Decision to associate charity with a cure turned it into Europe’s biggest funder of dementia research
Poor west African nation struggles with surge in use of toxic ‘kush’
Ageing is a long-term trend that investors can bank on
UK pharma body criticises maker of Ozempic and Wegovy over failure to report £7.8mn in transfers of value
A spinout of the medtech’s orthopaedics business would unlock value while shifting to the US could also deliver gains
Shares in London-listed maker of medical devices jump as holdings disclosed
New compound increases strength of antidote for fentanyl and other lethal drugs
New agreement hands UK drugmaker control of developing jabs and provides cash injection for German group
New drug Kisunla will be 20% more than rival as drugmaker claims it requires fewer treatments
Pfizer and BioNTech infringed pharmaceutical group’s mRNA patent, High Court in London rules
Federal health officials step up efforts to boost jab stockpiles in response to widening outbreak
Party will look to align health service in England more closely with DHSC in bid to cut waiting lists if it wins election
If the Grim Reaper is coming for you, there’s not much money can do to prevent it
Neurotech advance gives patients in MIT study walking speed and control closer to people who had not lost limbs
Sale of most of FairJourney Biologics means London-based owner GHO Capital realises close to 10-fold return
Owner of Boots and Duane Reade sees stretched customers and lower prescription reimbursements hitting margins